Linagliptin and Metformin Hydrochloride Tablets(Ⅱ)

Boehringer Ingelheim International GmbH🇨🇳 National Medical Products Administration

Approval Id: 8DqcFG2Wxsz
Approval Number: 国药准字HJ20170164
Generic Name: 利格列汀二甲双胍片(Ⅱ)
Generic Name En: Linagliptin and Metformin Hydrochloride Tablets(Ⅱ)
Trade Name: 欧双宁
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含利格列汀2.5mg与盐酸二甲双胍850mg
Reg Date: 2021-09-02
Expired Date: 2026-09-01
Company Name: Boehringer Ingelheim International GmbH
Production Company Name: Dragenopharm Apotheker Püschl GmbH
Company Detail Path: /organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path: /organization/dragenopharm-apotheker-puschl-gmbh

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 2, 2021

Approval ID

8DqcFG2Wxsz

Type

化学药品